MJH Life Sciences is presenting a webinar today on this important topic.
Investigators and scientists are racing the clock to develop a vaccine to prevent SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).
As multiple vaccine candidates are being studied, questions arise.
With so much research in this area, MJH Life Sciences is presenting a webinar titled COVID-19: Race for a Vaccine.
Join us today at 6pm EDT for a 1-hour live webinar event in infectious disease, virology, and vaccinology to hear a breakdown of the top vaccine candidates, the latest from the ongoing clinical trials, and how to combat logistical hurdles associated with the rollout of a vaccine in the middle of a global pandemic.
With a handful of candidates entering phase 3 trials, huge investments from governments for the first 100 million doses, case counts continuously ticking upward, and policymakers working to untangle the logistical knots of distribution, the race for a COVID-19 vaccine is one of the most urgent public health challenges we’ve ever encountered.
This webinar will feature the top minds in the field including:
Orenstein is a professor of medicine, of pediatrics, of global health, and of epidemiology at Emory University School of Medicine and associate director of the Emory Vaccine Center. He spent 26 years with the U.S. Immunization Program for the Centers for Disease Control and Prevention (CDC), including 16 years as program director.
Rasmussen is an associate research scientist and virologist at Columbia University. She is studying host responses to infection by combining classical virology with modern systems biology approaches. Her research objectives are to identify host response signatures predictive of infection severity or disease outcome and host pathways to target drug development or repurposing.
Poland, Vaccine Research Group at the Mayo Clinic, studies the immunogenetics of vaccine response in adults and children. Poland and his team aim to improve the health of individuals across the world by pursuing challenges posed by infectious diseases and bioterrorism through clinical, laboratory, and epidemiologic vaccine research.
Attendees will be able to ask our panel questions during the webinar.
Don’t miss out on this must-attend event! Sign up here.